MAPT and Alzheimer disease: This is seen in Alzheimer disease and in tauopathies (where tau accumulates in the cytoplasm), in Parkinson disease (where α-synuclein is the major component of the aggregates), and in polyglutamine expansion diseases like Huntington disease, where the mutant protein is the primary constituent of the aggregates.